RxDoctor Payments Data

Michael Kadoch, MD

Diagnostic Radiology · New York, NYNPI 1770716276

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $48,255 of the $73,535 with a category attached, or 65.6%. Boehringer Ingelheim accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $62,436 and has fallen 98.5% since, to $945 in 2021. Among diagnostic radiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$73,535in general payments, 2019–2025

Across 58 payments — averaging $1267.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$74K
  • Biotronik Inc.$20

What the payments were for

  • Consulting fees$12,18217%
  • Speaking & faculty fees$48,25566%
  • Travel & lodging$11,22215%
  • Food & beverage$1,8763%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim57$73,515
Biotronik Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,535 in reported general payments places this provider in the 95th percentile of 2,530 diagnostic radiology providers in New York.

See all diagnostic radiology providers in New York →

Medicare billing

Part B allowed, 2024
$396,140
Medicare patients
3,009
Services billed
58,770

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →